Why is BPD life expectancy so low?

People diagnosed with borderline personality disorder (BPD) die roughly 17 to 20 years earlier than the general population, a gap driven not by one cause but by a convergence of suicide risk, chronic physical illness, biological stress responses, lifestyle disruption, and a healthcare system that often fails them at every turn.¹ The scale of this gap is closer to what you see in serious chronic diseases than what most people imagine for a psychiatric diagnosis. Understanding why requires looking well beyond the headline association with suicide.

How Large Is the Life Expectancy Gap

One of the clearest estimates comes from a study that tracked people with personality disorders in England and Wales and found life expectancy at birth was about 63 years for women and 59 years for men, roughly 18 to 19 years shorter than their counterparts in the general population.² The standardized mortality ratio in that cohort was over four times what you would expect for a matched population. That means someone with a personality disorder diagnosis was dying at more than four times the rate of someone of the same age and sex without one. Men with personality disorders had nearly three times the expected rate of death from natural causes alone, even setting suicide aside entirely.³

These numbers should land hard. A 20-year reduction in lifespan is in the same territory as the gap associated with heavy smoking or untreated type 2 diabetes. And yet, while those conditions receive aggressive public health campaigns, the physical health consequences of BPD remain poorly recognized by clinicians and patients alike.

Suicide Risk Is Real but Not the Whole Story

Suicide is the most visible driver. A large meta-analysis pooling data from over 34,000 patients with BPD found that roughly 80 percent experienced suicidal thoughts at some point, about half made at least one attempt, and around 6 percent ultimately died by suicide.⁴ A long-running prospective study tracking BPD patients over 24 years put the suicide rate at about 5.9 percent, compared to 1.4 percent among people with other personality disorder diagnoses.⁵ That same study found something equally striking: 14 percent of borderline patients died of non-suicide causes over the follow-up period, compared to 5.5 percent of comparison subjects. In other words, for every person with BPD who died by suicide, more than two died of something else entirely.

This is the part the public conversation routinely misses. Suicide prevention is crucial, but even if every suicide were prevented, people with BPD would still be dying far younger than they should. The non-suicide mortality rate alone tells you something is fundamentally wrong with their physical health trajectory.

The Cardiovascular and Metabolic Burden

When researchers look at what is actually killing people with BPD outside of suicide, cardiovascular disease tops the list.¹ One study of patients with personality disorders and psychiatric comorbidities found that men had significantly elevated death rates specifically from cardiovascular and gastrointestinal disease.⁶

The metabolic groundwork for this starts early. A cross-sectional study found that the rate of metabolic syndrome among BPD patients was more than double that of comparison subjects, at roughly 23 percent versus 11 percent. The differences were driven by higher blood sugar, higher triglycerides, and greater abdominal obesity, all classic risk factors for heart disease and stroke.⁷ Imaging research has also shown elevated diabetes risk markers in BPD patients, including increased epicardial fat, a deposit around the heart that tracks closely with cardiovascular danger.⁸

People with BPD also carry a heavy burden of chronic pain conditions, gastrointestinal disease, arthritis, chronic fatigue, and back pain.⁹ Dysregulated pain perception in BPD appears to contribute to these outcomes by driving both chronic pain itself and higher rates of problematic substance use to manage it.¹⁰ Older patients with BPD tend to report more severe pain than younger ones, suggesting the problem compounds over time.¹¹

The Body’s Stress System Wears Down

A significant chunk of this physical deterioration traces back to how the body processes stress. In BPD, the hypothalamic-pituitary-adrenal axis, which controls the release of cortisol and other stress hormones, appears to be chronically dysregulated.¹² Most people with BPD have histories of adverse childhood experiences, and those early traumas can permanently alter the stress-response system along with neurotransmitter function, opioid signaling, and even brain structure.¹³ When cortisol runs high for years, it promotes fat storage around the abdomen, raises blood pressure, increases insulin resistance, and accelerates damage to blood vessels. The metabolic syndrome findings start to make more sense when you see them as downstream effects of a stress system that never got a chance to calibrate properly.

Perhaps the most direct evidence that BPD ages the body prematurely comes from epigenetic research. A study of women with emotionally unstable personality disorder and a history of suicide attempts found that their biological age, measured by a DNA methylation clock, exceeded their actual age by nearly nine years on average. In the control group, the gap was only about two years.¹⁴ Epigenetic age acceleration is not just an abstract biomarker. It predicts real-world outcomes like earlier onset of age-related disease and shorter lifespan. A roughly seven-year gap in biological aging goes a long way toward explaining a 20-year gap in life expectancy once you account for all the other risk factors piling on top.

Substance Use and Sleep Disruption

About 78 percent of adults with BPD develop a substance use disorder at some point in their lives.¹⁵ That is not a moderate overlap; it is a near-universal comorbidity. People with both BPD and addiction are more impulsive, drop out of treatment more often, and have shorter periods of sobriety. The combination amplifies nearly every mortality risk: overdose, liver disease, impaired decision-making, and neglect of other health conditions all become more likely.

Sleep is another area where the damage accumulates quietly. About 63 percent of people meeting full BPD criteria report at least one chronic sleep problem, and the average duration of those sleep difficulties is roughly 20 weeks, more than double the average in people without BPD.¹⁶ Trouble falling asleep, waking during the night, and waking too early were all significantly more common, and over a quarter of BPD patients had all three problems simultaneously. Chronic sleep deprivation is independently linked to heart disease, obesity, immune dysfunction, and worsened emotional regulation, which in BPD creates a feedback loop: poor sleep destabilizes mood, unstable mood disrupts sleep, and the body takes the damage from both.

Social Isolation Feeds the Cycle

BPD is defined in part by unstable relationships, and that instability comes at a physical cost. People with BPD tend to have fragile social support networks, and the loneliness that results is not just emotionally painful but medically dangerous. Research has linked this social isolation to increased rates of cardiovascular disease, hypertension, gastrointestinal disease, arthritis, chronic fatigue, and back pain among BPD patients.⁹ Social connection is a well-established buffer against chronic disease in the general population, and its absence removes one of the strongest protective factors a person can have.

Socioeconomic factors make this worse. A systematic review found a bidirectional relationship between social determinants of health and BPD: poverty, housing instability, and lack of education can trigger or worsen BPD symptoms, and BPD symptoms in turn make it harder to maintain employment, stable housing, and insurance coverage.¹⁷ Each direction of the cycle chips away at the practical ability to manage health conditions, get preventive care, or even eat well.

A Healthcare System That Makes Things Worse

You might expect that people this medically vulnerable would receive intensive physical health monitoring. The opposite often happens. A qualitative study of adults with BPD in physical healthcare settings found that medical professionals routinely attributed genuine physical symptoms to their psychiatric diagnosis, delaying tests and diagnoses for months. Participants described losing consciousness and sustaining years of physical damage before their symptoms were taken seriously.¹⁸ This phenomenon, where a psychiatric label causes clinicians to dismiss physical complaints as psychological in origin, is widespread and well-documented for BPD specifically.

The medications prescribed to manage BPD symptoms can also compound the physical risk. Despite the absence of any medication approved specifically for BPD, many patients end up on combinations of antipsychotics, mood stabilizers, and sedatives. Antipsychotic medications carry risks of significant weight gain and increased likelihood of developing diabetes.¹⁹ Clinicians using atypical antipsychotics for BPD crisis management have been warned to consider the long-term metabolic effects, including weight gain, diabetes, and elevated blood lipids, and to monitor for these outcomes routinely.²⁰ In practice, many patients with BPD stay on these medications for years without adequate metabolic screening.

Emergency departments illustrate the breakdown in care from another angle. Even patients who are actively case-managed and under the care of a psychiatrist or psychologist continue to seek help in emergency settings, suggesting they are not receiving timely evidence-based treatment in the community.²¹ A small number of patients account for a disproportionate share of crisis and emergency visits, pointing to either inadequate community resources, treatment-resistant complexity, or both.²² Emergency-driven care is reactive by nature. It stabilizes crises but does virtually nothing for the slow-moving cardiovascular and metabolic conditions that are actually killing people with BPD.

Sex Differences in How BPD Kills

The patterns of excess mortality are not the same for men and women with BPD, and the differences are striking. In a Norwegian cohort, women with personality disorder diagnoses had nearly 18 times the expected rate of unnatural death and 38 times the expected rate of suicide compared to the general female population. Men with personality disorders had about 10 times the expected unnatural death rate and 15 times the expected suicide rate.³ Women’s mortality from natural causes was not significantly elevated in that study, while men’s was nearly three times higher than expected. A separate study found the same divergence: women with BPD had dramatically elevated suicide rates, while men showed significantly elevated death from cardiovascular and gastrointestinal disease.⁶

What this means in practical terms is that the mix of interventions needed to improve survival depends partly on sex. For women with BPD, suicide prevention and crisis response are disproportionately important. For men, addressing cardiovascular risk factors and chronic physical disease management might close more of the gap. Both groups need both kinds of attention, but the emphasis should shift.

What Treatment Can and Cannot Do Right Now

Psychotherapy remains the primary evidence-based treatment for BPD, with several approaches showing moderate effectiveness in randomized trials, including dialectical behavior therapy, mentalization-based therapy, transference-focused therapy, and schema therapy. No single approach has proved superior to the others, and effect sizes for reducing core BPD symptoms are moderate. The harder truth is that almost half of patients do not respond sufficiently to psychotherapy.²³

The nonresponse rate matters for the life expectancy question because therapy’s benefits are not just psychological. Effective therapy reduces self-harm and substance use, improves relationship stability, and helps patients engage more consistently with other forms of healthcare. A patient who does not respond to therapy, or who cannot access it, loses all of those downstream protections. And therapy itself is designed primarily to address psychiatric symptoms and interpersonal functioning, not cardiovascular risk or metabolic health. Even when therapy works well, patients still need a medical system that monitors their physical health, takes their physical symptoms seriously, and minimizes the metabolic side effects of any concurrent medications.

The Role of Psychiatric Comorbidity

BPD rarely exists in isolation. Co-occurring depression is extremely common, but the way it interacts with other risk factors matters. A study using coronial data found that among people with BPD who died by suicide, those without co-occurring depression actually had higher rates of psychotic disorder diagnoses than either those with both BPD and depression or those with depression alone.²³ Substance use disorders and anxiety disorders were also significantly more prevalent among those with BPD compared to those with depression alone. Each additional diagnosis introduces its own physical health risks and treatment complications, creates new opportunities for medication interactions, and makes consistent engagement with care harder to sustain.

This layering of conditions is part of why the life expectancy gap is so wide. It is not that BPD alone produces a 20-year reduction; it is that BPD almost always brings companions, and each companion extracts its own toll on the body while making the others harder to treat.

Why Epigenetic Aging Research Matters Going Forward

The finding that women with BPD and suicidal history showed biological aging nearly nine years ahead of their actual age has implications beyond explaining the mortality gap.¹⁴ If accelerated aging is a measurable feature of BPD, it could eventually serve as a biomarker for identifying patients who are at highest physical risk, even before cardiovascular or metabolic disease becomes clinically obvious. It also opens a door to interventions that target biological aging pathways directly, which is an area of active research in gerontology that has not yet been connected to personality disorder treatment in any meaningful way.

The broader implication is that BPD may need to be reconsidered as a condition with a significant physiological component, not just a disorder of emotional regulation and interpersonal functioning. The stress system changes, the metabolic disruptions, the chronic pain, and now the epigenetic data all point toward a body that is aging faster and breaking down sooner. Treating BPD as a purely psychological problem, which is how most clinical frameworks still approach it, leaves the physical half of the mortality gap essentially unaddressed.